Coenzyme Q 10 reverses mitochondrial dysfunction in atorvastatin-treated mice and increases exercise endurance

Journal of Applied Physiology

Volumn 113, Issue 3, 2012, Pages 479-486

  Muraki, Ayako ^a   Miyashita, Kazutoshi ^a   Mitsuishi, Masanori ^a   Tamaki, Masanori ^a   Tanaka, Kumiko ^a   Itoh, Hiroshi ^a  

^a KEIO UNIVERSITY   (Japan)

Author keywords

Coenzyme Q 10; Exercise; Mitochondria; Oxygen utilization; Statins

Indexed keywords

ATORVASTATIN; DRUG DERIVATIVE; HEPTANOIC ACID DERIVATIVE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LACTIC ACID; PRAVASTATIN; PYRROLE DERIVATIVE; UBIDECARENONE; UBIQUINONE;

ANIMAL; ANIMAL EXPERIMENT; ARTICLE; BIOSYNTHESIS; C57BL MOUSE; DRUG ANTAGONISM; DRUG EFFECT; ENDURANCE; HISTOLOGY; MALE; MOUSE; MUSCLE CELL; MUSCLE MITOCHONDRION; MUSCLE STRENGTH; ORGAN SIZE; OXYGEN CONSUMPTION; PHYSIOLOGY; SKELETAL MUSCLE;

ANIMALS; HEPTANOIC ACIDS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; LACTIC ACID; MALE; MICE; MICE, INBRED C57BL; MITOCHONDRIA, MUSCLE; MUSCLE CELLS; MUSCLE STRENGTH; MUSCLE, SKELETAL; ORGAN SIZE; OXYGEN CONSUMPTION; PHYSICAL CONDITIONING, ANIMAL; PHYSICAL ENDURANCE; PRAVASTATIN; PYRROLES; UBIQUINONE;

EID: 84864616144     PISSN: 87507587     EISSN: 15221601     Source Type: Journal    
DOI: 10.1152/japplphysiol.01362.2011     Document Type: Article

References (33)

1. Aragonés J, Schneider M, Van Geyte K, Fraisl P, Dresselaers T, Mazzone M, Dirkx R, Zacchigna S, Lemieux H, Jeoung NH, Lambrechts D, Bishop T, Lafuste P, Diez-Juan A, Harten SK, Van Noten P, De Bock K, Willam C, Tjwa M, Grosfeld A, Navet R, Moons L, Vandendriessche T, Deroose C, Wijeyekoon B, Nuyts J, Jordan B, Silasi-Mansat R, Lupu F, Dewerchin M, Pugh C, Salmon P, Mortelmans L, Gallez B, Gorus F, Buyse J, Sluse F, Harris RA, Gnaiger E, Hespel P, Van Hecke P, Schuit F, Van Veldhoven P, Ratcliffe P, Baes M, Maxwell P, Carmeliet P. Deficiency or inhibition of oxygen sensor Phd1 induces hypoxia tolerance by reprogramming basal metabolism. Nat Genet 40:170-180, 2008. (Pubitemid 351171394)
2. Arany Z, Lebrasseur N, Morris C, Smith E, Yang W, Ma Y, Chin S, Spiegelman BM. The transcriptional coactivator PGC-1beta drives the formation of oxidative type IIX fibers in skeletal muscle. Cell Metab 5:35-46, 2007. (Pubitemid 44939399)
3. Baigent C, Keech A, Kearney PM, Blackwell L, Buck G, Pollicino C, Kirby A, Sourjina T, Peto R, Collins R, Simes R; Cholesterol Treatment Trialists' (CTT) Collaborators. Efficacy and safety of cholesterollowering treatment: prospective meta-analysis of data from 90, 056 participants in 14 randomised trials of statins. Lancet 366:1267-1278, 2005.
4. 10: absorption, tissue uptake, metabolism and pharmacokinetics. Free Radic Res 40:445-453, 2006.
5. Bisgaier CL, Essenburg AD, Auerbach BJ, Pape ME, Sekerke CS, Gee A, Wölle S, Newton RS. Attenuation of plasma low density lipoprotein cholesterol by select 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors in mice devoid of low density lipoprotein receptors. J Lipid Res 88:2502-2515, 1997. (Pubitemid 28028135)
6. Bruckert E, Hayem G, Dejager S, Yau C, Bégaud B. Mild to moderate muscular symptoms with high-dosage statin therapy in hyperlipidemic patients-The PRIMO Study. Cardiovasc Drugs Ther 19:403-414, 2005. (Pubitemid 43228152)
7. 10 on myopathic symptoms in patients treated with statins. Am J Cardiol 99:1409-1412, 2007. (Pubitemid 46686635)
8. Chen R, Feldstein AE, McIntyre TM. Suppression of mitochondrial function by oxidatively truncated phospholipids is reversible, aided by bid, and suppressed by Bcl-XL. J Biol Chem 284:26297-26308, 2009.
9. Dang CV, Gao P. Muscle fatigue from losing your PHD. Cell Metab 7:191-192, 2008. (Pubitemid 351285534)
10. *3-Leiden. CETP mice. Atherosclerosis 197:57-63, 2008. (Pubitemid 351273273)
11. Delahoy PJ, Magliano DJ, Webb K, Grobler M, Liew D. The relationship between reduction in low-density lipoprotein cholesterol by statins and reduction in risk of cardiovascular outcomes: an updated metaanalysis. Clin Ther 31:236-244, 2009.
12. Delliaux S, Steinberg JG, Lesavre N, Paganelli F, Oliver C, Jammes Y. Effect of long-term atorvastatin treatment on the electrophysiological and mechanical functions of muscle. Int J Clin Pharmacol Ther 44:251-261, 2006. (Pubitemid 43853398)
13. Dobkin BH. Underappreciated statin-induced myopathic weakness causes disability. Neurorehabil Neural Repair 19:259-263, 2005. (Pubitemid 41216302)
14. Harper CR, Jacobson TA. The broad spectrum of statin myopathy: from myalgia to rhabdomyolysis. Curr Opin Lipidol 18:401-408, 2007. (Pubitemid 47051918)
15. Hirofuji C, Nakatani T, Ishihara A, Tanaka M, Itoh K, Itoh M, Katsuta S, Ibata Y. Cell size and succinate dehydrogenase activity of different types of fibers in different regions of the tibialis anterior muscle in mice and rats. Acta Histochem Cytochem 33:295-303, 2000. (Pubitemid 32011999)
16. Hsiang B, Zhu Y, Wang Z, Wu Y, Sasseville V, Yang WP, Kirchgessner TG. A novel human hepatic organic anion transporting polypeptide (OATP2): identification of a liver-specific human organic anion transporting polypeptide and identification of rat and human hydroxymethylglutaryl-CoA reductase inhibitor transporters. J Biol Chem 274:37161-37168, 1999.
17. Ishii N, Nakahigashi K, Baba T, Robert M, Soga T, Kanai A, Hirasawa T, Naba M, Hirai K, Hoque A, Ho PY, Kakazu Y, Sugawara K, Igarashi S, Harada S, Masuda T, Sugiyama N, Togashi T, Hasegawa M, Takai Y, Yugi K, Arakawa K, Iwata N, Toya Y, Nakayama Y, Nishioka T, Shimizu K, Mori H, Tomita M. Multiple high-throughput analyses monitor the response of E. coli to perturbations. Science 316:593-597, 2007. (Pubitemid 46683144)
18. Johnson J, Carson K, Williams H, Karanam S, Newby A, Angelini G, George S, Jackson C. Plaque rupture after short periods of fat feeding in the apolipoprotein E-knockout mouse: model characterization and effects of pravastatin treatment. Circulation 111:1422-1430, 2005. (Pubitemid 40396809)
19. Kamzalov S, Sumien N, Forster MJ, Sohal RS. Coenzyme Q intake elevates the mitochondrial and tissue levels of coenzyme Q and alphatocopherol in young mice. J Nutr 133:3175-3180, 2003. (Pubitemid 37222237)
20. Kim JW, Tchernyshyov I, Semenza GL, Dang CV. HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia. Cell Metab 3:177-185, 2006.
21. 10 level in statin-related myopathy. Arch Neurol 62:1709-1712, 2005. (Pubitemid 41626667)
22. 10: an update. Nutrition 26:250-254, 2010.
23. 10, and liver and muscle enzyme levels in hypercholesterolemic patients treated with atorvastatin: a randomized double-blind study. Atherosclerosis 195:e182-e189, 2007. (Pubitemid 350087984)
24. Mitsuishi M, Miyashita K, Muraki A, Itoh H. Angiotensin II reduces mitochondrial content in skeletal muscle and affects glycemic control. Diabetes 58:710-717, 2009.
25. Miyashita K, Itoh H, Tsujimoto H, Tamura N, Fukunaga Y, Sone M, Yamahara K, Taura D, Inuzuka M, Sonoyama T, Nakao K. Natriuretic peptides/cGMP/cGMP- dependent protein kinase cascades promote muscular mitochondrial biogenesis and prevent obesity. Diabetes 58:2880-2892, 2009.
26. 10: is there a clinical role and a case for measurement? Clin Biochem Rev 29:71-82, 2008.
27. Nakazato K, Song H. Increased oxidative properties of gastrocnemius in rats fed on a high-protein diet. J Nutr Biochem 19:26-32, 2008. (Pubitemid 350213392)
28. 10 in rats and humans after single oral intake. J Nutr Sci Vitaminol 53:187-190, 2007. (Pubitemid 46933030)
29. Päivä H, Thelen KM, Van Coster R, Smet J, De Paepe B, Mattila KM, Laakso J, Lehtimäki T, von Bergmann K, Lütjohann D, Laaksonen R. High dose statins and skeletal muscle metabolism in humans: a randomized, controlled trial. Clin Pharm Ther 78:60-68, 2005. (Pubitemid 40956932)
30. 10 supplementation rescues renal disease in Pdss2kd/kd mice with mutations in prenyl diphosphate synthase subunit 2. Am J Physiol Renal Physiol 295:F1535-F1544, 2008.
31. Sattar N, Preiss D, Murray HM, Welsh P, Buckley BM, de Craen AJ, Seshasai SR, McMurray JJ, Freeman DJ, Jukema JW, Macfarlane PW, Packard CJ, Stott DJ, Westendorp RG, Shepherd J, Davis BR, Pressel SL, Marchioli R, Marfisi RM, Maggioni AP, Tavazzi L, Tognoni G, Kjekshus J, Pedersen TR, Cook TJ, Gotto AM, Clearfield MB, Downs JR, Nakamura H, Ohashi Y, Mizuno K, Ray KK, Ford I. Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials. Lancet 375:735-742, 2010.
32. 2 cells treated with high dose simvastatin: a possible role in statin-induced hepatotoxicity? Toxicol Appl Pharmacol 223:173-179, 2007. (Pubitemid 47348060)
33. Thompson PD, Clarkson P, Karas RH. Statin-associated myopathy. JAMA 289:1681-1690, 2003 (Pubitemid 37430274)